Contact
Please use this form to send email to PR contact of this press release:
Adial Pharmaceuticals Regains Compliance with Nasdaq Listing Requirement
TO:
Please use this form to send email to PR contact of this press release:
Adial Pharmaceuticals Regains Compliance with Nasdaq Listing Requirement
TO: